Veradermics, Inc. (MANE)
122.28
+13.46
(+12.37%)
USD |
NYSE |
Oct 19, 16:00
124.00
+1.72
(+1.41%)
Pre-Market: 20:00
Veradermics Total Assets (Quarterly) : 826.33M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 826.33M |
| March 31, 2026 | 398.58M |
| December 31, 2025 | 154.47M |
| Date | Value |
|---|---|
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | 59.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 142.28B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.12M |
| Shareholders Equity (Quarterly) | 814.21M |
| Debt to Equity Ratio | 0.0005 |
| Current Ratio | 70.53 |
| Net Debt Paydown Yield | 0.00% |